Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)

Clinical trial NCT04721795 · COMPLETED

Trial details

NCT number: NCT04721795
Sponsor: Obafemi Awolowo University Teaching Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary Tuberculosis

Start date: 2021-01-19
Primary completion: 2022-03-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.